Josemaria Resources Inc. (TSX: JOSE) (OTCQB: JOSMF) Focused on Readily Developable Copper-Gold Project as Demand Rises

 

• Demand for copper is rising; deficit forecast in coming years
• Copper deficit heightens need for projects that can produce the high-demand metal
• Feasibility study concluded that Josemaria’s average annual metal production of 136,000 tonnes of copper (“Cu”), 231,000 ounces of gold (“AU”), 1,164, 000 ounces of silver (“Ag”)
• Strategic plan demonstrates commercial production at project could be achieved by early 2026

The looming copper deficit will likely worsen in the coming years, according to an S&P Global Market Intelligence report (https://nnw.fm/ADKEV). That news is capturing the attention of companies such as Josemaria Resources (TSX: JOSE) (OTCQB: JOSMF), a Canadian natural resources company focused on the development of its wholly owned Josemaria copper-gold mining project.

“A deficit in the copper market is set to deepen over the next several years as supply of the widely used metal struggles to keep up with strong demand from the power and construction sectors, compounded by the proliferation of electric vehicles,” reported the S&P article, which was titled “Copper supply faces struggle to keep up with growing demand.” The article noted that refined output is expected to increase by 4.3% year on year to 24.7 million tonnes in 2021 after decreasing by 2.1% to 23.6 Mt in 2020—primarily as a result of disruptions caused by the coronavirus pandemic.

Highly attuned to market demands, Josemaria Resources is working to develop its flagship property — the Josemaria Copper-Gold Project — as quickly as possible. The project is located in the San Juan Province of Argentina, a well-known mining hub supporting a wide variety of mining and service companies.

Josemaria just recently announced the results of an independent feasibility study evaluating the property (https://nnw.fm/JJyKO). In short, the study concluded that the property is a “robust, rapid pay-back, low-risk project, with an open-pit operation feeding a conventional process plant at 152,000 tonnes per day over a 19 year mine life, yielding average annual metal production of 136,000 tonnes of copper (‘Cu’), 231,000 ounces of gold (‘Au’) and 1,164,000 ounces of silver (‘Ag’).”

“We are extremely pleased with the results of the Feasibility Study at Josemaria, which indicates that this is one of the very few readily developable copper-gold projects in the world today,” said Josemaria Resources president and CEO Adam Lundin. “This study has materially de-risked the project and forecasts an attractive economic outcome, which is comparable with other large-scale copper/gold projects already being developed or in production today. We believe that Josemaria is perfectly positioned to commence production by mid-decade, meeting rising copper demand from a rapidly electrifying global economy. I believe the study results will allow us to unlock various financing opportunities as we move toward construction.”

Josemaria Resources has already begun a bridging phase of engineering, which will be followed by the initiation of basic engineering planned for early 2021. The company’s clear and achievable project execution plan and its strong industry position demonstrate commercial production at the project could be achieved by early 2026, ideally timed to meet the growing copper deficit (https://nnw.fm/aL1O4).

Josemaria Resources is a Canadian natural resources company based in Vancouver, British Columbia. The company is part of the Lundin Group of companies, a conglomerate of 13 business entities operating in the mining, oil and gas and renewables sectors around the world.

For more information, visit the company’s website at www.JosemariaResources.com.

NOTE TO INVESTORS: The latest news and updates relating to JOSMF are available in the company’s newsroom at https://nnw.fm/JOSMF 

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Positive Preclinical Data for Potential Anxiety Treatment

 

• VTGN CEO “even more excited about PH94B’s potential to change lives without the risky side effects and safety concerns of benzos”
• Study results suggest PH94B’s mechanism of action may not have benzodiazepine-like side effects, such as sedation, cognitive impairment or abuse liability
• Company making significant progress in preparing PH94B for launch of pivotal Phase 3 study for acute treatment of anxiety in adults with social anxiety disorder

VistaGen Therapeutics (NASDAQ: VTGN) has reported new preclinical findings differentiating the mechanism of action of PH94B from that of benzodiazepines (https://nnw.fm/1rXwV). PH94B is an intranasal neuroactive steroid VistaGen is preparing for Phase 3 development as a potential acute rapid-onset treatment of anxiety in adults with social anxiety disorder. As a solution to anxiety notably lacking the notorious side effects of traditional medications, the formulation could be a game-changer to the world of mental health.

“We are very pleased with the results of these studies that suggest PH94B’s mechanism of action may not have benzodiazepine-like side effects, such as sedation and cognitive impairment, or abuse liability,” said VistaGen CEO Shawn K. Singh. “While benzodiazepines provide relief for many Americans struggling with anxiety, the extremely risky safety profile does not lend itself to long-term use. The mechanism of action contributes to the safety profile.”

VistaGen, a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, reported that new in vitro electrophysiology data demonstrating that PH94B’s mechanism of action does not involve direct activation of GABA-A receptors. That is in direct contrast to the mechanism of action of benzodiazepines (benzos), which act as direct positive modulators of GABA-A receptors.

“As we have seen in Phase 2 clinical studies, while PH94B is able to produce rapid-onset benzo-like, anti-anxiety effects, this study demonstrates that PH94B does not have a benzo-like mechanism of action,” noted Singh. “As we approach Phase 3 development of PH94B, especially given the FDA’s recent public announcement about safety concerns associated with benzo use, these new data make us even more excited about PH94B’s potential to change lives without the risky side effects and safety concerns of benzos.”

In additional news, VistaGen also provided business updates and released its financial results for the fiscal 2021 second quarter ended September 30, 2020 (https://nnw.fm/FchMK). Key highlights for the company included a positive FDA meeting that outlined the pathway to a key PH94B Phase 3 study beginning recruitment Q2 2021, along with news that the company had received more than $17.5 million in net proceeds from a public offering of common stock and a PH94B upfront license payment. The company also noted positive new data had been gathered from its second preclinical study of AV-101 in combination with probenecid.

“We see a significant rise in mental health concerns as the global COVID-19 pandemic continues to impact the daily lives of millions of individuals,” observed Singh. “We are committed to developing innovative therapies that provide relief to those suffering from anxiety and depression, and we are working diligently towards that goal.

“We are making significant progress in preparing PH94B for launch of a pivotal Phase 3 study for acute treatment of anxiety in adults with social anxiety disorder in the second quarter of 2021,” he continued. “After reaching consensus with the FDA on the key components of the study design, it will be very similar to the statistically significant Phase 2 study of PH94B in social anxiety disorder. We are also working with the FDA to finalize details for our Phase 2A study of PH94B in adjustment disorder, which we are planning to initiate in early 2021.”

VistaGen is a clinical-stage biopharmaceutical company developing new generation medicines for anxiety, depression and other CNS disorders where the current standard of care is inadequate, resulting in high unmet need. Each of VistaGen’s three drug candidates has a differentiated mechanism of action, an exceptional safety profile in all studies to date and therapeutic potential in multiple CNS markets.

For more information, visit the company’s website at www.VistaGen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://nnw.fm/VTGN

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

As World Transitions away from Gas Guzzlers, Net Element Inc. (NASDAQ: NETE) Entering EV Market Through Mullen Technologies Merger

 

• NETE plans to divest payments processing model to enter EV industry through proposed merger with privately-held Mullen Technologies Inc.
• Merger allows Mullen stakeholders to obtain majority of stock while accelerating process of taking company public, funding US expansion
• Mullen accepting reservations for Dragonfly K50 sports car and MX-05 SUV, production for both projected to start in 2021
• California-based Mullen subsidiaries include Mullen Energy, Mullen Auto Sales, Mullen Finance Corp., CarHub digital marketplace

Future generations may look back and wonder how humanity withstood the exhaust fumes, noise and environmental degradation created by fossil fuel engines. The downsides of combustible engines, rising fuel prices and positive government incentives are all factors driving EVs into the mainstream – and some experts predict purely electric models will surpass hybrids during the transition. Net Element (NASDAQ: NETE), through its proposed merger with Mullen Technologies, is planning to divest its payments processing business model to enter the burgeoning EV industry. The strategic move will allow the stakeholders of privately held Mullen to gain a majority of the new stock while catalyzing the process of taking the company public and accelerating its expansion in the United States.

The bold move comes at a time of rapid industry expansion amid growing concern for the environment among the general public and policy-makers. Falling battery prices, government mandates and consumer incentives are propelling the industry forward, prompting some industry experts to predict that the pure electric models will surpass hybrids within the next few years as the transition takes place.

“I think we’ll see a faster transition to pure EVs,” said Dane Parker, an industry executive and participant at Business Insider’s IGNITION: Transportation virtual event (https://nnw.fm/1Liq5). Besides his belief that hybrids are more complex to engineer, Parker predicts that by 2025 battery prices will have dropped substantially, resulting in the accelerated adoption of pure electric vehicles and their eventual dominance over hybrids.

Through its subsidiaries that include Mullen Auto Sales, Mullen Finance Corp., a digital marketplace called CarHub and battery-focused Mullen Energy, Mullen Technologies has already made significant headway in the US. Among the company’s expansion plans is the production of the Dragonfly K50 luxury electric sports car at its new proposed 1.3 million square-foot assembly and manufacturing space in Spokane, Washington. Featuring a Rechargeable Energy Storage System (RESS), the Dragonfly boasts a range of up to 310 miles and can accelerate from 0-60 miles/hour in under 4.2 seconds. Limited to only 1000 units, the company has started accepting reservations with production set to begin next year.

Pre-orders for another Mullen vehicle – the five-passenger MX-05 – have also begun. Production for the pure electric all-wheel SUV is set to begin in 2021 with deliveries set for mid-2022. Starting at $55,000, the MX-05 boasts a range of 325 miles on a single charge and can hit 60 miles/hour from zero in just 3.2 seconds.

Formerly a global financial technology and value-added solutions group, NETE plans to leverage the increased demand for electric vehicles through a proposed merger with Mullen Technologies. Based in California, Mullen Technologies engages in electric vehicle manufacturing across an international distribution network, partnering with several original equipment manufacturers across the world to provide exciting EV options for the US market.

For more information, visit the company’s website at www.NetElement.com.

NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at  http://nnw.fm/NETE

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Amid Pandemic’s Battering on Hemp / CBD Markets, HempFusion Wellness Inc. Sees Brighter Future

 

• Denver-based HempFusion Wellness, Inc. has developed 46 products and 8 OTC FDA listed topicals that draw on the versatile compounds in hemp for promoting effective sleep, stress reduction, pain relief, skin care and “smooth energy” pick-me-ups
• Despite a downturn in the hemp and CBD product industries brought on by the worldwide COVID-19 pandemic, HempFusion is anticipating a market rebound amid positive developments in legal, political and medical research arenas
• Market analysts at Brightfield Group anticipate improvement in the CBD sector to $12.4 billion by 2023 and $16.8 billion by 2025
• HempFusion has filed a preliminary prospectus for a planned initial public offering of its stock in Canada and a listing on the Toronto Stock Exchange under the symbol CBD.U

Legal cannabis consumers have already become well aware of the hammering the industry has taken during the COVID-19 era. Market outlooks have been revised sharply downward as many retailers selling CBD products have closed temporarily or transitioned to curbside pickup and delivery, and farmers have reduced their hemp acreage. But nearly a year into the global pandemic, there have been bright spots as well.

While the health crisis has impacted product movement, the legal front lines continue to advance. The European Union’s highest court declared this month that cannabidiol (“CBD”) is not a narcotic drug, despite some EU countries’ efforts to control it on such health-related grounds (https://nnw.fm/6Zd2H). In the United States, the presidential elections delivered an apparent victor who favors decriminalization of marijuana, if not outright legalization, while additional states joined the drive toward relaxed legislation within their boundaries (https://nnw.fm/CPwiq). And pandemic-related stress is credited with driving sales increases in some areas (https://nnw.fm/qa3SL).

CBD brand HempFusion Wellness is optimistic about renewed energy in the marketplace, mirroring its products’ aim to help restore energy and wellness balances to its consumers.

“Researchers have newly discovered a system inside of our body that has been affectionately named the endocannabinoid system,” CEO Jason Mitchell explains in a video outlining the company’s operations (https://nnw.fm/x4BWH). “What’s really special about it is that in this identification they have found an intricate network of receptors located throughout the entire body that interconnect all of the biological systems together. They’ve deemed it a regulatory system because it helps to maintain and support homeostasis or balance inside the body.”

Mitchell notes that hemp is plant source of cannabinoids that may interact with the body’s system, citing the company’s varied products as able to promote effective sleep, stress reduction, pain relief, skin care and “smooth energy” via liquid tinctures and taste-free liquid capsules, thanks in part to their full-spectrum delivery and combination with other natural elements, such as adaptogen herbs.

“The name HempFusion means hemp fused together with other products,” Mitchell states.

Researchers at market analysis firm Brightfield Group forecast a CBD marketplace worth $10 billion this year and $23 billion by 2023 before the pandemic swept the planet. They have since revised their outlook downward to $12.4 billion by 2023 and $16.8 billion by 2025 (https://nnw.fm/PcfZa).

However, the rapid-response effort to deliver a potential COVID-19 vaccine has led some media outlets to predict the end of the pandemic is in sight (https://nnw.fm/8i3CC), which could open the gates to a restored sense of excitement about world economic recovery and CBD products’ return to previous expectations if the relatively new technology of mRNA-based vaccines proves sustainable.

HempFusion has developed 46 products and announced last month that it has produced a preliminary prospectus with securities regulatory authorities in Canada for a proposed initial public offering that could land its common shares in all of the provinces but Quebec as it lists on the Toronto Stock Exchange. That makes HempFusion the first U.S.-based CBD company to apply to list on the TSX (https://nnw.fm/3T8nH).

For more information, visit the company’s website at www.HempFusion.com/Corporate-Information.

NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://nnw.fm/HempFusion

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Emerging Functional Mushroom Market Ripe with Potential for Rritual Superfoods’ New Product Line

 

• Rritual Superfoods, Inc. is positioning itself to supply the emerging demand for high-potential mushrooms dietary elixirs as wellness products that combat stress, enhance immunity against disease and increase mental clarity
• Market analysts predict the overall functional foods industry will reach revenues of $268 billion by 2027, and that the functional mushroom segment will grow at a CAGR of 8.04 percent by 2024 as part of the trend
• Rritual was recently certified by the USDA as an organic product, providing third-party validation Rritual’s quality protocols
• Rritual’s initial product launch includes elixirs containing mushroom and adaptogenic herb blends such as Chaga-Eleuthero, Lion’s Mane-Rhodiola and Reishi-Ashwagandha combinations

The recently concluded election cycle in the United States revealed that a growing number of people, regardless of political affiliation, are continuing to explore their options for boosting their wellness and mental flexibility, even including the use of some products that have long been classified as illegal (https://nnw.fm/MQ43T). As a prime example, Oregon has gained significant attention for passing its measure to legalize the hallucinogenic compound in “magic mushrooms” for mental health treatment in supervised settings (https://nnw.fm/JQptw).

Rritual Superfoods is pushing to become a leader in an emerging mushroom market, but not the one that’s gaining attention from hallucinogenic users and their opponents. Rather, Rritual is among innovators calling attention to the health benefits of “functional fungi” — the dietary mushrooms that have enjoyed health-promoting status for centuries in Asian countries in particular.

“Mushrooms have long been used in Asia for their ability to improve health, maintain vitality, preserve a youthful appearance, and to counter the adverse health effects of chronic stress,” integrative medicine specialist Dr Andrew Weil told the United Kingdom’s Evening Standard (https://nnw.fm/wP11C). “Research also demonstrates that a variety of traditional mushrooms possess anti-bacterial, anti-viral and immune-enhancing properties.”

Rritual Superfoods recently announced the launch of three elixir varieties available in 14-stick packs and in 250-gram tubs during the fall, as well as a 14-day variety pack that includes all three formulations. The company’s website indicates that the products are currently sold out, but will be available in North America during the first quarter of 2021 (https://nnw.fm/zy8fS).

The elixirs are a Chaga blend designed to boost the immune system, a Lion’s Mane blend designed to support mental clarity and brain health, and a Reishi blend to boost the body’s ability to fight anxiety. Each elixir blend combines these superfood mushroom varieties with adaptogenic herbal roots and other non-superfood mushrooms engineered to deliver these specific benefits.

“All mushrooms are good for us and contain beneficial levels of antioxidants and other plant chemicals, but those called ‘medicinal’ simply have greater levels,” nutritional therapist Grace Kingswell told the Evening Standard.

Chaga, in particular, is known as the “king of mushrooms” and contains an unusually high level of antioxidants with beta glucan-rich polysaccharides that give it powerful immune system-supporting capacity, whereas Reishi has been used for over 2,000 years in China.

On Nov. 12, the company announced it has secured organic certification from the U.S. Department of Agriculture (“USDA”), hailed by CEO David Kerbel because it provides “trusted, third-party validation of the quality of Rritual’s products,” whereas many wellness products market themselves as containing “all-natural” ingredients, which does not indicate regulatory examination (https://nnw.fm/8Mr2z).

People generally turn to wellness-boosting products during the winter season as a means of keeping their energy levels high and health intact when temperatures are colder and the sunshine is less potent, making the next few months a prime time for making Rritual’s products available to the public. Particularly during a period of pandemic-level population infection.

Market analysts predict the general functional foods industry will see $268 billion in revenues by 2027, growing at a CAGR of 6.7 percent until then (https://nnw.fm/xiNkF). Mordor Intelligence’s analysts predict the global functional mushroom market will grow with a CAGR of 8.04 percent between 2019 and 2024 (https://nnw.fm/uBTjz).

For more information, visit the company’s website at https://investors.wearerritual.com.

“Mental Fitness is a Daily Ritual”

NOTE TO INVESTORS: The latest news and updates relating to Rritual are available in the company’s newsroom at https://nnw.fm/Rritual

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

As Global Cannabis Sales Grow 38% in 2020, Gage Cannabis Co. Expands to Offer Recreational Marijuana at Flagship Location

 

• Research suggests cannabis sales increased 38% from 2019 to 2020
• Gage expanding into fast-growing Michigan market, now offering recreational marijuana at flagship Ferndale location
• Adult-use cannabis revenues in Michigan projected at $1 billion per year for 2021, surpassing $1.5 billion by 2023
• Quarterly sales nearly doubled to $11.9 million in Q2 2020 from $5.8 million in Q1, expected to surpass $13.1 million in Q3

Recent research published by BDSA (formerly BDS Analytics) suggests that the global cannabis industry continues to grow despite COVID-19, with forecasts predicting that 2020 sales will reach $19.7 billion – an increase of 38% from 2019 (https://nnw.fm/OzcUj). One of Michigan’s fastest-growing cannabis brands, Gage Cannabis has expanded accordingly by offering recreational marijuana at its flagship Ferndale location. Gage is committed to building a solid reputation by providing top-tier cannabis experiences for the rapidly growing Michigan market.

“We have been looking forward to this day since we opened our doors in September 2019,” said Gage Cannabis President and Executive Vice President of Operations Mike Finos. “We are excited to extend the Gage experience to anyone aged 21 and over. Metro Detroit is home to our biggest consumers, and we’re ready to provide the community with quality products and a unique customer experience.”

Recreational use of cannabis in Michigan was first legalized in 2018, and the state has since emerged as one of the fastest-growing legal cannabis markets in the country in terms of consumption. Revenue projections by state budget planners suggest that the recreational marijuana market will be worth nearly $1 billion in fiscal 2021 with the potential to increase to $1.5 billion by 2023 (https://nnw.fm/9slXZ).

“Michigan is one of the top cannabis markets in the U.S., and I am confident Gage is poised to continue building on its historical execution and fortifying its position as one of the top operators and brands in Michigan, as well as a name consumers look for across the United States,” said Gage Cannabis Executive Chairman Bruce Linton (https://nnw.fm/PriCl).

Gage produces its own in-house brands in addition to collaborating with several strategic partners and recognized names such as California-based Cookies – an iconic lifestyle brand widely known for its high-end cannabis strains and association with Berner, a rapper from the Bay Area. Sales bloomed during the COVID-19 lockdown period, nearly doubling to $11.9 million in Q2 from $5.8 million in Q1. The trend is expected to continue with management forecasting sales to surpass $13.1 million by the end of Q3 – an increase of over 150% from January to September 2020 (https://nnw.fm/PgGRO). The company is currently planning to go public with a Canadian listing in early 2021 and has launched a Regulation A, Tier 2, equity financing.

To learn more about the company’s Regulation A financing, visit www.GageInvestors.com.

For more information, visit the company’s website at www.GageUSA.com.

NOTE TO INVESTORS: The latest news and updates relating to Gage Cannabis are available in the company’s newsroom at https://nnw.fm/GAGE

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Rritual Superfoods’ Extensive Distribution Network Set to Take Functional Mushrooms Mainstream

 

• Functional Mushrooms Market Set for CAGR of 5.6%
• Expected to Reach $24.85 billion by 2026
• Rritual Superfoods Has Launched Three Mushroom-based Products
• Products Boost Immune System, Brain Power and Relieve Stress
• Company’s Extensive Distribution Network Set to Accelerate Sales

Consumers today shop for food with a number of considerations in mind, including food safety and the health benefits of their selected grocery items. This has resulted in increased demand for functional foods, with one sector — functional mushrooms — projected to increase at a CAGR of 5.6% during 2021–2026. This would put the market for functional mushrooms at $24.85 billion by the end of the forecast period. Rritual Superfoods is one of the companies operating in this nascent market.

Founded in 2019, Rritual has, to date, brought three mushroom-based products to market and is in the process of developing others. Rritual is working to ensure that its offerings not only augment the physical and psychological condition of consumers but also provide a healthy return for shareholders.

Functional foods, which are becoming increasingly popular, are foods that promote good health beyond the requirements of basic nutrition. Although the term “functional foods” may be relatively new, some traditional foods that fall into that category, such as oatmeal and orange juice fortified by calcium, are already staples in many diets.

Rritual is going a step beyond fortification. Rather than enhance the health benefits of food by adding nutrients, the company has developed its superfood offerings to be standalone supplements, which offers greater flexibility for consumers. With Rritual, consumers don’t need to consume more protein, carbohydrates or fats to receive the benefits.

Presently, Rritual Superfoods has three products derived from the chaga, lion’s mane, and reishi mushrooms. Rritual’s chaga blend boosts the immune system. Combined with the eleuthero root, the chaga-infused product, which also contains bioactive polysaccharides, increases resilience in the immune system and helps ward off infection.

The lion’s mane product is a brain booster. Its unique blend of lion’s mane mushroom and rhodiola root supports cognitive function and brain health, while also improving the body’s ability to cope with stress.

The reishi-based product also helps in dealing with stress. It includes the Ashwagandha root to help in combating anxiety and is rich in triterpenes, polysaccharides, fatty acids, and amino acids. Long-term use is said to improve the quality of sleep.

Rritual has devised a global sales and distribution strategy that covers three major markets: the United States, Canada, and Japan, through a growing network of online sales together with brick-and-mortar distribution.

For more information, visit the company’s website at https://investors.wearerritual.com.

Mental Fitness Is A Daily Ritual.

NOTE TO INVESTORS: The latest news and updates relating to Rritual are available in the company’s newsroom at https://nnw.fm/Rritual

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.